Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLCNNASDAQ:GNOMNASDAQ:SPCNASDAQ:TARK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLCNSiren Nasdaq NexGen Economy ETF$22.12-0.6%$20.04$16.24▼$30.66$46.01M1.5915,419 shs7,381 shsGNOMGlobal X Genomics & Biotechnology ETF$8.40+0.5%$7.77$6.80▼$11.88$50.90M1.0362,670 shs92,652 shsSPCCrossingBridge Pre-Merger SPAC ETF$21.32+0.3%$21.05$18.82▼$22.08$30.91M0.0323,226 shs442 shsTARKTradr 2X Long Innovation ETF$44.77+3.9%$31.74$18.25▼$61.52$101.18M5.56109,992 shs134,856 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLCNSiren Nasdaq NexGen Economy ETF-0.58%+6.91%+7.38%+8.50%-17.00%GNOMGlobal X Genomics & Biotechnology ETF+0.48%+6.06%+12.00%-4.55%-19.39%SPCCrossingBridge Pre-Merger SPAC ETF0.00%+0.19%+1.14%+1.91%-1.34%TARKTradr 2X Long Innovation ETF+3.90%+17.69%+43.31%+50.13%+51.74%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLCNSiren Nasdaq NexGen Economy ETFN/AN/AN/AN/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/ASPCCrossingBridge Pre-Merger SPAC ETFN/AN/AN/AN/AN/AN/AN/AN/ATARKTradr 2X Long Innovation ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLCNSiren Nasdaq NexGen Economy ETF 2.72Moderate Buy$22.12N/AGNOMGlobal X Genomics & Biotechnology ETF 2.69Moderate Buy$8.40N/ASPCCrossingBridge Pre-Merger SPAC ETF 0.00N/AN/AN/ATARKTradr 2X Long Innovation ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLCNSiren Nasdaq NexGen Economy ETFN/AN/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/AN/AN/AN/AN/AN/ASPCCrossingBridge Pre-Merger SPAC ETFN/AN/AN/AN/AN/AN/ATARKTradr 2X Long Innovation ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLCNSiren Nasdaq NexGen Economy ETFN/AN/A19.27∞N/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/A-$2.34N/A∞N/AN/AN/AN/AN/ASPCCrossingBridge Pre-Merger SPAC ETFN/AN/A38.96∞N/AN/AN/AN/AN/ATARKTradr 2X Long Innovation ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLCNSiren Nasdaq NexGen Economy ETF$0.130.59%N/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/A0.00%N/AN/AN/ASPCCrossingBridge Pre-Merger SPAC ETF$1.125.25%N/AN/AN/ATARKTradr 2X Long Innovation ETF$0.250.56%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLCNSiren Nasdaq NexGen Economy ETFN/AGNOMGlobal X Genomics & Biotechnology ETF56.95%SPCCrossingBridge Pre-Merger SPAC ETFN/ATARKTradr 2X Long Innovation ETFN/AInsider OwnershipCompanyInsider OwnershipBLCNSiren Nasdaq NexGen Economy ETFN/AGNOMGlobal X Genomics & Biotechnology ETF5.89%SPCCrossingBridge Pre-Merger SPAC ETFN/ATARKTradr 2X Long Innovation ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLCNSiren Nasdaq NexGen Economy ETF147,0002.08 millionN/AOptionableGNOMGlobal X Genomics & Biotechnology ETFN/A6.06 millionN/AOptionableSPCCrossingBridge Pre-Merger SPAC ETFN/A1.45 millionN/AOptionableTARKTradr 2X Long Innovation ETFN/A2.26 millionN/AOptionableTARK, SPC, BLCN, and GNOM HeadlinesRecent News About These CompaniesOptions Trading Now Available on Three Tradr ETFs: QBTX, TEMT and APPXMay 22, 2025 | standard-journal.comTop Performing Leveraged/Inverse ETFs: 05/18/2025May 21, 2025 | etftrends.comInvestment Managers Series Trust II - Tradr 2X Long Innovation 100 Quarterly ETFMay 21, 2025 | money.usnews.comInvestment Managers Series Trust II - Tradr 2X Long Innovation 100 Monthly ETFMay 21, 2025 | money.usnews.comMatt Mankiewicz on Tradr 2X Long QBTS Daily ETF (QBTX)May 20, 2025 | msn.comTop Performing Leveraged/Inverse ETFs: 03/23/2025March 26, 2025 | etftrends.comTop Performing Leveraged/Inverse ETFs: 12/08/2024December 11, 2024 | etftrends.comNovember Turns Out to Be the Best Month: 5 Top Leveraged ETFs (Revised)December 3, 2024 | zacks.comNovember Turns Out to Be the Best Month: 5 Top Leveraged ETFsDecember 2, 2024 | zacks.comTradr 2X Short Innovation Daily ETF (SARK)November 20, 2024 | finance.yahoo.comSPYQ Tradr 2X Long SPY Quarterly ETFNovember 15, 2024 | seekingalpha.comTop Performing Leveraged/Inverse ETFs: 11/10/2024November 13, 2024 | etftrends.comQQQP Tradr 2X Long Triple Q Quarterly ETFOctober 29, 2024 | seekingalpha.comQQQP Tradr 2X Long Triple Q Quarterly ETFOctober 29, 2024 | seekingalpha.comQQQW Tradr 2X Long Triple Q Weekly ETFOctober 25, 2024 | seekingalpha.comTradr 2X Long Triple Q Quarterly ETF (QQQP)October 23, 2024 | finance.yahoo.comTLTM Tradr 2X Long TLT Monthly ETFOctober 22, 2024 | seekingalpha.comTARK Tradr 2X Long Innovation ETFOctober 19, 2024 | seekingalpha.comTradr 2X Long Innovation ETF (NASDAQ:TARK), Short Interest ReportOctober 11, 2024 | benzinga.comTradr 2X Long SPY Quarterly ETF (SPYQ)October 10, 2024 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTARK, SPC, BLCN, and GNOM Company DescriptionsSiren Nasdaq NexGen Economy ETF NASDAQ:BLCN$22.12 -0.13 (-0.58%) Closing price 06/9/2025 04:00 PM EasternExtended Trading$22.25 +0.13 (+0.59%) As of 06/9/2025 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Siren Nasdaq NexGen Economy ETF (BLCN) is an exchange-traded fund that is based on the Siren NASDAQ Blockchain Economy index. The fund tracks an index of global companies involved in developing, researching, or using blockchain technologies. BLCN was launched on Jan 17, 2018 and is managed by Siren.Global X Genomics & Biotechnology ETF NASDAQ:GNOM$8.40 +0.04 (+0.48%) Closing price 06/9/2025 03:54 PM EasternExtended Trading$8.38 -0.02 (-0.24%) As of 04:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.CrossingBridge Pre-Merger SPAC ETF NASDAQ:SPC$21.32 +0.06 (+0.28%) As of 06/9/2025 10:26 AM EasternThe CrossingBridge Pre-Merger SPAC ETF (SPC) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that invests in pre-merger Special Purpose Acquisitions Companies. SPC was launched on Sep 21, 2021 and is issued by CrossingBridge Funds.Tradr 2X Long Innovation ETF NASDAQ:TARK$44.77 +1.68 (+3.90%) Closing price 06/9/2025 04:00 PM EasternExtended Trading$45.31 +0.54 (+1.20%) As of 05:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The AXS 2X Innovation ETF (TARK) is an exchange-traded fund that is based on the ARK Innovation ETF index. The fund is an actively-managed fund-of-fund that seeks to achieve 2x the return, for a single day, of the ARK Innovation ETF (ARKK) through swap agreements with major global financial institutions. TARK was launched on May 2, 2022 and is managed by AXS Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Tightly-Held Growth Stocks Set Up for Short Squeezes Palantir Stock Holds Support, Despite Political Backlash Science Applications International Is a Wicked Hot Buy in June Why Unity Software May Be the AI Breakout No One Saw Coming Tesla Stock Dips to Buy Zone—Robotaxi Catalyst Ahead? Is Lululemon’s 18% Selloff Overdone? Analysts Say Yes MarketBeat Week in Review – 06/02 - 06/06 This Banking Giant Just Got a $90 Price Target Upgrade Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
